Kerr, F., Sofola-Adesakin, O., Ivanov, D. K., Gatliff, J., Perez-Nievas, B. G., Bertrand, H. C., . . . Partridge, L. Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationKerr, Fiona, et al. Direct Keap1-Nrf2 Disruption as a Potential Therapeutic Target for Alzheimer's Disease. Public Library of Science (PLoS).
MLA (9th ed.) CitationKerr, Fiona, et al. Direct Keap1-Nrf2 Disruption as a Potential Therapeutic Target for Alzheimer's Disease. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.